PharmaBoardroom

2020: A Watershed Year for Chinese Biotech

2020 will certainly go down in history as a watershed year for the global community, as a new strain of coronavirus – later named SARS-CoV-19 –…

Key Challenges for Life Sciences & Healthcare in 2020:…

‘The Key Challenges: Life Sciences and Healthcare 2020’ is the latest report from Cornerstone International Group based on a global survey of…

Johnsee Lee – Chairman & CEO & Eric Yang –…

Johnsee Lee and Eric Yang of Taiwanese precision medicine diagnostics firm Quark Biosciences outline their technology’s unique characteristics, how…

“Medication Adherence” is a Lunatic Endeavour

John G. Singer outlines why a focus on patients' adherence to their medication is not necessarily useful in working to improve health outcomes and why…

Kyung Suk Kim – CEO, Corestem

Kyung Suk Kim, CEO of Corestem, the first company to receive approval for a stem cell therapy for Amyotrophic Lateral Sclerosis (ALS) in Korea,…

Latin America Pharma News Roundup June 2020

In recent pharma news from around Latin America, countries are beginning to manufacture their own tests and equipment for dealing with the COVID-19…

China Biotech News Roundup June 15th 2020

A roundup of the latest news from Chinese biotechs, including a bumper IPO for Legend Biotech, a USD two million tie-up between Roche and Innovent…

COVID-19: 95% of US Rare Disease Patients Affected

As of 11 June 2020, there have been over two million confirmed cases of COVID-19 in the US and over 115,000 deaths, with the US having occupied the…

Pharma Faces: Bae Byoungjun, KoNECT, Korea

With over 30 years of experience in public office working in public health and pharmaceutical policy, food and drug safety regulations, national…

Top 10 Pharma Companies in Japan

Japan's pharma market is one of the world's biggest, with a value of around USD 95 billion, according to figures from the country's Ministry of…

Parallel Trade in Belgium: Rebuffing the Critics

Stakeholders from the Belgian parallel trade industry outline how their activities are helping to solve medicine shortages in Europe and ensure…

Updates on Authorization Fees in Algeria

Drugs, biologicals and medical devices authorization fees are fixed as part of Finance Law in Algeria. Fees are payable by the person who makes the…

Tagged with A